Schwieterman, J., Ansari, S., Azam, M. (2025). Selective degradation of oncogenic signaling nodes by momelotinib-based protacs exerts potent anti-leukemic response in B-ALL, AML, and MF while sparing normal cells. Blood. https://doi.org/10.1182/blood-2025-6108